In early July, India slid into the third spot for highest COVID-19 cases worldwide and the pressing need for mass vaccination assumed the center-stage. As population density and vast geographies continue to pose issues in controlling the spread of the coronavirus outbreak, the health experts debate the unfolding of community spread of CO- VID-19. India’s medical research institutes and pharmaceutical manufacturing companies have been rapidly expanding their already voluminous production capacities and accelerating vaccine development in response to the outbreak. With these capabilities, India is poised to be a key global player in effectively countering the pandemic through the production and distribution of vaccinations.
Over the last decade, India has emerged as a global pharmaceuticals and vaccine hub. Globally, it is one of the largest suppliers of generic medicines, occupying20% share of global supplies, ranking third in terms of proportion and tenth rank in terms of value. Outside of the US, India has the largest number of FDA compliant pharmaceutical plants and has nearly 1400WHO approved pharmaceutical manufacturing units with the latest technologies; the country houses over 10,500 manufacturing facilities operating under 3,000 innovative pharmaceutical companies.
هذه القصة مأخوذة من طبعة August 2020 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 2020 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Granules' Visakhapatnam - Unit V facility passes FDA inspection
Granules India's Unit V facility in Visakhapatnam has completed US FDA inspection with zero 483 observations.
Mankind to set up 'Digital Smart Classrooms' in villages
Under the project, Mankind Pharma to equip 220 government schools from Uttar Pradesh, Himachal Pradesh, and Uttarakhand with learning tools and technology.
Indegene acquires medical writing player from Germany
Indegene acquires Trilogy Writing & Consulting GmbH, enhancing medical writing capabilities for life sciences companies.
Medulance bags 25.06 cr series-A VC funding
Latest VC funding to be invested in expanding emergency healthcare in India.
HUMAN TOUCH IN HEALTHCARE
Healthcare must prioritize empathy, not efficiency, for better patient experience, moving from cost center to core strategy, argues author
SMART BANDAGES A REVOLUTION IN WOUND CARE
Wound care is about to get a technological upgrade! See how next-generation intelligent dressings may help to fight infections and assist in the fast healing of wounds
THE EMERGING THREAT OF LUPUS
Explore the prevalence and growth rates of Lupus in India and ways to tackle this emerging healthcare challenge.
INDIA'S NURSES' SHORTAGE: FINDING CURE
The acute scarcity of nurses is burdening India's healthcare system, risking patient care outcomes. Explore the way forward.
New guidelines to address fluid management in hospitalized patients
API and Kenvue India release guidelines for managing oral fluids, electrolytes, and energy in non-diarrheal patients for hospitals in India.
HealthTech hiring stays strong despite funding slowdown - Report
India's HealthTech hiring demonstrates resilience with employment surging by nine percent amidst a funding deceleration.